Opus Genetics starts MERTK RP gene therapy trial
Opus Genetics (Nasdaq: IRD) launched a clinical trial for OPGx-MERTK, an AAV-based gene therapy for...
Opus Genetics (Nasdaq: IRD) launched a clinical trial for OPGx-MERTK, an AAV-based gene therapy for...
Listen to this articleEstimated 4 minutesThe audio version of this article is generated by AI-based technology. Mispronunciations can occur. We...
Infant Mental Health Awareness Week is acknowledged in Australia from 10 – 16 June, providing an opportunity to discuss the...